Nanomedicine News

RSS

CASIS Awards Grant to Develop Remotely Controlled Nanochannel Drug Delivery System

Houston Methodist Research Institute scientists will receive about $1.25 million from the Center for the Advancement of Science in Space to develop an implantable device that delivers therapeutic drugs at a rate guided by remote control. The device's effectiveness will be tested aboard the International Space Station and on Earth's surface.

27 Oct 2014

Novel Nanoparticle Delivers Melanoma-Fighting Drug Directly to the Cancer

Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.

25 Oct 2014

New Report on Global Market for Anti-Microbial Nanocoatings

Research and Markets has announced the addition of the "The Global Market for Anti-Microbial Nanocoatings" report to their offering.

25 Oct 2014

Smarter, More Targeted Nanotherapy Could Overcome Lethal Gynecologic Cancer

Physicians will tell you: They are not winning the war on ovarian cancer. But Florida International University researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering to create a smarter, more targeted therapy that could overcome the most lethal gynecologic cancer.

25 Oct 2014

Tiny ‘Nanodomain’ Structures with Concentrated ANK3 Gene Levels Linked to Bipolar Disorder

A nano-sized discovery by Northwestern Medicine® scientists helps explain how bipolar disorder affects the brain and could one day lead to new drug therapies to treat the mental illness.

24 Oct 2014

Hybrid Diagnostic ‘Nanodecoder’ for Improvement of Cancer Treatment

Cancer diagnostics and treatment options could be drastically improved with the creation of a ‘designer’ nanodevice being developed by researchers from the UK, Italy, the US and Argentina.

24 Oct 2014

NuVascular Commercializes Nanotechnology-Based Electrospinning Process for Creating Medical Devices

NuVascular Technologies, Inc. is commercializing its patented electrospinning process to create new medical devices that help millions.

17 Oct 2014

French ANSM Grants Approval for Nanobiotix’s NBTXR3 Phase II/III Registration Trial for Soft Tissue Sarcoma

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced today that it has received approval from the French National Security Agency for Medicines and Health Products (ANSM) to start its Phase II/III registration trial of its lead product, NBTXR3, in patients with locally advanced Soft Tissue Sarcoma (STS).

From Nanobiotix 16 Oct 2014

Niels Bohr Institute Professor Honored with Prize for 'Research Excellence in Nanotechnology'

Charles Marcus, who is a professor and head of the Center for Quantum Devices at the Niels Bohr Institute at the University of Copenhagen, has been awarded the prize for 'Research Excellence in Nanotechnology' by the nanoscience centre, NBIC at the University of Pennsylvania, USA. It is an international prize and is given in recognition of outstanding research in nanotechnology.

16 Oct 2014

Selecta, JDRF add Sanofi in Partnership to Develop Synthetic Vaccine Particle Immunotherapy for Diabetes

Selecta Biosciences, Inc., and JDRF, announced today that they have extended their joint research collaboration and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle (SVP™) immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes.

16 Oct 2014

Nanomedicine News

CASIS Awards Grant to Develop Remotely Controlled Nanochannel Drug Delivery System

Novel Nanoparticle Delivers Melanoma-Fighting Drug Directly to the Cancer

New Report on Global Market for Anti-Microbial Nanocoatings

Smarter, More Targeted Nanotherapy Could Overcome Lethal Gynecologic Cancer

Tiny ‘Nanodomain’ Structures with Concentrated ANK3 Gene Levels Linked to Bipolar Disorder

Hybrid Diagnostic ‘Nanodecoder’ for Improvement of Cancer Treatment

NuVascular Commercializes Nanotechnology-Based Electrospinning Process for Creating Medical Devices

French ANSM Grants Approval for Nanobiotix’s NBTXR3 Phase II/III Registration Trial for Soft Tissue Sarcoma

Niels Bohr Institute Professor Honored with Prize for 'Research Excellence in Nanotechnology'

Selecta, JDRF add Sanofi in Partnership to Develop Synthetic Vaccine Particle Immunotherapy for Diabetes

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting